Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ

Details Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ

1995-06-02

1996-12-24

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 31495

Patent

active

055873766

ABSTRACT:
A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R.sub.1 and R.sub.2 each is selected from the group consisting of alkyl radicals containing 1 to 4 carbon atoms and alkoxy radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R.sub.3, R.sub.4 and R.sub.5 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as constriction of one or more blood vessels and decongestion of one or more nasal passages.

REFERENCES:
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4188393 (1980-02-01), Neuman
patent: 4656291 (1987-04-01), Maryanoff et al.
patent: 5021416 (1991-06-01), Gluchowski
patent: 5034406 (1991-07-01), Gluchowski
patent: 5077292 (1991-12-01), Gluchowski
patent: 5112822 (1992-05-01), Gluchowski
patent: 5130441 (1992-07-01), Gluchowski
patent: 5198442 (1993-03-01), Gluchowski
patent: 5204347 (1993-04-01), Gluchowski
patent: 5231096 (1993-07-01), Gluchowski
patent: 5237072 (1993-08-01), Gluchowski
Berridge et al, Br. J. Pharmac., 88(2), 345-354, 1986.
Thaina et al, J. Autonomic Pharmacology, 13(2), 95-176, 1993.
Hayes et al, Neuropharmacology, 25(4), 391-396, 1986.
Gellai et al, Am. Physio. Soc., F317-323, 1988.
Contiello et al, J. Biol. Chem., 264 (27), pp. 16000-16007, 1989.
Thaina et al, J. Auton Pharmacol, vol. 3, No. 2, pp. 115-126, Apr. 1993.
Williams et al, J. Auton Pharmacol, 10(4):247, Aug. 1990 Abstract.
Hillebrand et al. J. Pharmacol Exp. Ther., 263(2) pp. 510-519, Nov. 1992 Abstract.
Fondacaro, J. Pharmacol Exp. Ther., 247(2), pp. 481-486, Jul. 1988.
C. F. Colpaert, CA 105:481U, 1986.
Colpaert, F., Drug Development Research, 7(3), 209-220, 1986.
Dharmsathaphorn et al, Gastroenterology, 86(1), 120-128, 1984.
Hieble et al, The Pharmacol, 82, pp. 152, Aug. 1991.
Goodman & Gilman et al, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 8, pp. 174-179, 1985.
Fondacaro et al, American Society for Pharmacology, vol. 247, 1987, pp. 481-486.
Bendele et al, Pharmacol, 82, p. 152, Aug. 1991.
Jumblatt et al, Current Eye Research, vol. 6, pp. 767-777, 1987.
Burke et al, Current Eye Research, vol. 5, pp. 665-676, 1986.
Bloor et al, Anesthesia & Analgesia, vol. 61, No. 9, 741-745, Sep. 1982.
Van Zwieten et al, Advances in Drug Research, vol. 13, 209-254, 1984.
Dharmsathaphorn, Gastroenterology, 91(3), 769-70, 1986.
Sato et al, Science, vol. 251, pp. 1608-1610, Mar. 1991.
Gellai et al, The Journal of Pharmacology & Exp. Therap., 240(3), pp. 723-728, 1987.
Jarrot, Hardbook of Hypertension, vol. 5, pp. 113-168, 1988.
Langer et al, Journal of Cardiovascular Pharm., vol. 7, Supp. 8 (SI-S8), 1986.
Nielsen et al, Br. J. Pharmacol, 97 (834), 1989.
B. Bloor, Seminars in Anesthesia, vol. VII, No. 3, pp. 170-177, Sep. 1988.
Fielding, Midicinal Research Reviews, vol. 1, No. 1, pp. 97-123, 1981.
Isom et al, The Fournal of Biological Chemistry, vol. 262, No. 14, pp. 6750-6757, May 1987.
Pieter et al, Med. Chem., vol. 4, pp. 323-329, 1980.
Boudier et al, Chemical Abstracts, vol. 82, No. 17, p. 13, 1975.
Mittag, Annals of Ophthalmology, 15(3), 201-202, 1983.
Steppler et al, Chemical Abstracts, vol. 91, No. 21, p. 43, 1979.
Steppler et al, Chamical Abstracts, vol. 90, No. 5, p. 37, 1979.
Timmermans et al, Chemical Abstracts, 89:474AV, 1978.
Philippu et al, Chemical Abstract, vol. 99, No. 15, p. 137, 1983.
Ekas et al, Chemical Abstracts, 98:210440t, 1983.
Chemical Abstracts, vol. 98, 98:921X, 1982.
Chemical Abstracts, 91:168403M, 1979.
Walland, Chamical Abstracts, vol. 88, No. 23, p. 80, 1978.
Hamilton, C., Pharmac. Ther. vol. 54 (3) (1992), pp. 231-248.
Bradley et al, Neuropharmacology, vol. 25, No. 4, Apr. 1986, pp. 391-396.

Affiliated with

Also associated with

Rating

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1178674